An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) [DELIVERS Study]

Trial Profile

An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) [DELIVERS Study]

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 10 Jul 2018

At a glance

  • Drugs Diacerein (Primary)
  • Indications Epidermolysis bullosa
  • Focus Registrational; Therapeutic Use
  • Acronyms DELIVERS
  • Sponsors Castle Creek Pharmaceuticals
  • Most Recent Events

    • 06 Feb 2018 Planned End Date changed from 1 May 2018 to 1 Jan 2019.
    • 06 Feb 2018 Planned primary completion date changed from 1 May 2018 to 1 Nov 2018.
    • 15 Jan 2018 According to a Castle Creek Pharmaceuticals media release, the phase II portion of this trial is completed and the phase III portion is ongoing.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top